MedTrace Logo

Kidney in Coronavirus Disease 2019 Registry

NCT04797091 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-12-17

No results posted yet for this study

Summary

The SARS-CoV-2 virus is a virus newly identified in January 2020. The WHO defined COVID-19 as a health emergency of international importance. The clinical manifestation of the COVID-19 disease cannot be fully described in the short time.

First insights in patients suffering from acute kidney injury (AKI) during COVID-19 indicate severe course with high mortality. The locally varying spread of SARS CoV-2 infection requires a better understanding of clinical course of COVID-19 in order to be able to establish future treatment approaches.

The examination of attributable mortality and costs of COVID-19 will need to be studied on a multinational basis and therefore Kidney in COVID-19 Registry will particularly use a matched case control design.

Conditions

  • Corona Virus Infection
  • SARS-CoV 2

Interventions

OTHER

Retrospective data collection

Retrospective data collection to overcome the lack of knowledge on epidemiology, clinical course including diagnostic and therapeutic approaches and prognostic factors for SARS-CoV-2-infections and their complications among nephrology and elderly patients, as well as to serve as a platform for future studies and outbreak situations.

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Volker Burst, PD MD · University Hospital of Cologne

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04797091 on ClinicalTrials.gov